Industry Distribution:

• Pharmaceutical Companies: approx. 45%
• Biotechnology: approx. 25%
• Healthcare Services: approx. 15%
• Medical Devices: approx. 15%

TOP 3 Markets:

• USA: approx. 65%
• Europe: approx. 20%
• Asia-Pacific: approx. 10%

The Vanguard Health Care ETF (VHT) mainly invests in companies from the healthcare sector, with the largest share going to pharmaceutical companies. This reflects the strong position and influence of these companies in the healthcare sector.

The USA is the dominant market, attributed to the size and innovation power of the American healthcare sector. Europe and the Asia-Pacific region follow, also making significant contributions to the ETF's revenue.

Vanguard World Fund - Vanguard Health Care ETF (ARCA:VHT) is an exchange-traded fund (ETF) and not a company that produces physical products.

This ETF invests in stocks of companies in the healthcare sector. Therefore, the ETF itself does not produce products but holds shares in various companies operating in the healthcare industry. The production locations of these companies vary depending on the specific company in which the ETF invests.

Current Strategy: Diversification and Innovation in the Healthcare Sector

The Vanguard Health Care ETF (VHT) pursues a strategy focused on diversification and innovation in the healthcare sector. The fund invests in a broad range of companies within the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services.

This diversification allows the ETF to benefit from various growth opportunities within the sector while spreading the risk. Vanguard places particular emphasis on selecting companies that invest in research and development to bring innovative products and services to the market.

Another strategic focus is on adapting to demographic changes, such as an aging population that brings increased demand for healthcare services and products. Vanguard leverages its extensive market analysis to invest in companies that can benefit from these long-term trends.

In summary, the Vanguard Health Care ETF pursues a sustainable growth strategy through a balanced mix of diversification, innovation, and adaptation to demographic trends.

Current data on specific commodity imports: Not directly available.

The Vanguard Health Care ETF (ARCA:VHT) is an exchange-traded fund that invests in companies in the healthcare sector. As an ETF, it does not directly import commodities or materials. Instead, it holds shares in various companies that may import commodities or materials.

Companies in the healthcare sector that could be part of the ETF portfolio typically import commodities such as pharmaceutical active ingredients, medical device components, and biotechnological materials. These are often sourced from countries like China, India, and Germany, which are significant production centers for pharmaceutical and medical products.

For detailed information on the specific imports of individual companies within the ETF, it would be necessary to review the reports of the respective companies.

Market share in the healthcare sector: approximately 10% (estimated 2025)
Assets under management (AUM): $20 billion USD (2025)
Expense ratio: 0.10% (2025)

The Vanguard Health Care ETF (ARCA:VHT) benefits from a significant competitive advantage due to its low expense ratio of 0.10%, which is very attractive compared to many other ETFs in the healthcare sector. This allows investors to cost-effectively invest in a diversified portfolio of healthcare companies.

Vanguard is known for its strong brand reputation and its ability to manage large assets, creating trust among investors. The ETF provides access to a wide range of companies in the healthcare sector, diversifying the risk for investors while increasing the chances of returns.

Additionally, the ETF benefits from the overall market development in the healthcare sector, supported by demographic trends such as an aging population and increasing healthcare spending. This further enhances the competitive advantage of VHT.

Institutional Investor Share: approximately 85% (estimated for 2025)

Insider Buys/Sells: No significant insider transactions known (2025)

The Vanguard Health Care ETF (VHT) is a popular fund among institutional investors, as evidenced by the high institutional investor share of around 85%. These investors appreciate the diversification and stability that the ETF offers, especially in the healthcare sector.

Insider transactions are less relevant for ETFs like VHT, as it is a passively managed fund that does not have direct influence from company insiders. Therefore, there are no significant insider buys or sells to report.

Market share of Vanguard Health Care ETF (ARCA:VHT): Estimated around 5-7% (2025)

Main competitors and their market shares:

1. iShares U.S. Healthcare ETF (IYH): around 8-10%
2. Health Care Select Sector SPDR Fund (XLV): around 10-12%
3. Fidelity MSCI Health Care Index ETF (FHLC): around 4-6%
4. SPDR S&P Health Care Equipment ETF (XHE): around 3-5%
5. Invesco Dynamic Pharmaceuticals ETF (PJP): around 2-4%

The Vanguard Health Care ETF (VHT) holds a moderate market share compared to its competitors. The largest competitor, the Health Care Select Sector SPDR Fund (XLV), has a significantly higher market share and leads in this segment.

Economic moat: VHT's economic moat lies in its broad diversification and cost-effective structure, which is a hallmark of Vanguard ETFs in general. These characteristics provide investors an attractive opportunity to invest in the healthcare sector without paying high fees.

Compared to competitors that may have more specialized or focused approaches, VHT offers a more comprehensive coverage of the sector. This can be seen as an advantage for investors who prefer broad diversification. However, specialized ETFs like the SPDR S&P Health Care Equipment ETF (XHE) or the Invesco Dynamic Pharmaceuticals ETF (PJP) may have a stronger economic moat in specific niches of the healthcare sector.

Overall, VHT has a solid, but not outstanding, economic moat compared to its competitors, who may excel through specialized strategies or larger market shares.

Assets Under Management (AUM): 18.5 billion USD (2024) Annual Expense Ratio: 0.10% (2024) Industry Focus: Healthcare

The Vanguard Health Care ETF (VHT) is a broadly diversified fund that invests in companies in the healthcare sector. With assets of 18.5 billion USD, the ETF offers significant size and liquidity. The annual expense ratio of 0.10% is very competitive, making the fund a cost-effective option for investors.

The healthcare sector is known for its stability and resilience to economic downturns, as the demand for healthcare services and products remains relatively constant. Additionally, the sector is supported by demographic trends such as an aging population and technological advances in the field of medical technology and biotechnology.

Investors interested in a long-term investment strategy and looking to benefit from the growth prospects of the healthcare sector may consider VHT as an attractive option. The diversification within the sector also provides risk mitigation compared to investing in individual stocks.

Dividend Yield: 1.2% (estimated for 2025)
Payout Frequency: Quarterly

The Vanguard Health Care ETF (VHT) is known for paying out a regular dividend. The dividend yield typically ranges from 1% to 2%, with the exact yield varying slightly from year to year. The payouts are made quarterly, which is attractive for investors seeking regular income.

Vanguard has a long history of reliable dividend payments, and the Health Care ETF benefits from the stability and growth potential of the healthcare sector. This makes the payouts relatively reliable, even in economically challenging times.